Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma-Reference-Cited by-同舟云学术

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma

Published:2004-09-23 Issue:11 Volume:18 Page:1879-1882
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kaufmann H,Ackermann J,Baldia C,Nösslinger T,Wieser R,Seidl S,Sagaster V,Gisslinger H,Jäger U,Pfeilstöcker M,Zielinski C,Drach J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403518.pdf

Reference22 articles.

1. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564–569.

2. Seidl S, Kaufmann H, Drach J . New insights into the pathophysiology of multiple myeloma. Lancet Oncol 2003; 4: 557–564.

3. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546–1558.

4. Hallek M, Bergsagel PL, Anderson KC . Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21.

5. Kuehl WM, Bergsagel PL . Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002; 2: 175–187.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse models of human multiple myeloma subgroups;Proceedings of the National Academy of Sciences;2023-02-28

2. Plasma cell neoplasms and related entities—evolution in diagnosis and classification;Virchows Archiv;2022-11-21

3. Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study;Translational Oncology;2022-09

4. Single-cell transcriptional analysis of the immune tumour microenvironment during myeloma disease evolution;2021-10-24

5. Preclinical models of human multiple myeloma subgroups;2021-08-28